Lipa Pharmaceuticals Limited
Lipa Pharmaceuticals Limited is an Australian B2B contract manufacturer of nutraceuticals and complementary medicines, offering private label and white label production across all major dosage formats and operating Australia's first TGA-compliant probiotic contract manufacturing facility for brand-owner clients.
- Company typePrivate
- Founded1995
- HeadquartersMinto, Australia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lipa Pharmaceuticals Limited does
Lipa Pharmaceuticals Limited is an Australian proprietary limited company headquartered in Minto, New South Wales, operating as a B2B contract manufacturer of nutraceutical and complementary medicines since the early 1990s. The company produces finished dietary supplements and listed therapeutic goods on behalf of brand-owner clients under both private label (custom formulation) and white label (pre-formulated) engagement models, with capabilities spanning hard shell capsules, soft gel capsules, tablets, chewables, powders, liquids, serums, gels and creams.
Its core technology platform is built around TGA-licensed GMP-certified manufacturing infrastructure, including the first TGA-compliant probiotic contract manufacturing facility in Australia, with in-house qPCR validation equipment for strain-level identification, fully segregated HVAC and environmental controls for probiotic production, world-class stability testing, and a recently installed liquids and cream plant supporting fills from 15 ml to 1 litre. Lipa also maintains a proprietary ingredient range (including affron, Almega PL, Oligopin, Olivactive, Levagen+, CoQ10, HydroCurc and Lutein) sourced through partnerships with Pharmactive Biotech, Qualitas Health, and BASF, with BASF's Prebilac 2'-FL HMO prebiotic offered exclusively in Australia via Lipa.
Revenue is generated through batch-based manufacturing fees under multi-year contracts, with annual price reviews, minimum order quantities of at least three batches per client per calendar year, and cited development budgets from A$0–A$10K up to A$50K+ alongside regular batch spend of A$50K–A$100K to A$200K+ (5,000 to 20,000+ finished goods). The go-to-market is sales-led and consultation-driven via an online intake form, supported by participation at international nutraceutical trade shows (Vitafoods Europe, SupplySide WEST, Healthplex Expo) and content marketing through the company's education hub. The company does not sell directly to consumers; clients distribute finished goods through their own retail, e-commerce, and practitioner channels. Customer segments include consumer brand businesses (private and white label), with an emerging pet supplements vertical under APVMA compliance.
Lipa Pharmaceuticals Limited firmographics
Firmographics- Name
- Lipa Pharmaceuticals Limited
- Legal name
- Lipa Pharmaceuticals Ltd
- Website
- https://lipa.com.au
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Lipa Pharmaceuticals Limited is an Australian B2B contract manufacturer of nutraceuticals and complementary medicines, offering private label and white label production across all major dosage formats and operating Australia's first TGA-compliant probiotic contract manufacturing facility for brand-owner clients.
- Ownership category
- akta.pro rank
Lipa Pharmaceuticals Limited industry classification
Industry- Product category
- Nutraceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
- akta.pro secondary industries
- Weight Management & Metabolic Supplements (CRADAGAG), Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC), Better-for-You / Functional Snacks (Low Sugar, Keto, Probiotic, Fortified) (CRADABAM)
Keywords
Where Lipa Pharmaceuticals Limited is headquartered
LocationHeadquarters
- HQ city
- Minto
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Lipa Pharmaceuticals Limited business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Lipa manufactures nutritional supplements and complementary medicines for B2B clients under private label (custom) and white label (pre-formulated) arrangements. Revenue is generated through manufacturing fees based on batch orders. Minimum order quantities apply — typically multiple orders per calendar year with minimum batch sizes per product. Pricing is based on Lipa's price list as notified to customers, with annual reviews. Regular batch spend cited in consultation form ranges from $50K–$100K (5K finished goods) up to $200K+ (20K+ finished goods).
- Proprietary Ingredient Range: Lipa maintains a key ingredient range (affron®, Almega PL®, Oligopin®, Olivactive®, Levagen+™, Coenzyme Q10, HydroCurc®, Lutein, etc.) which it incorporates into client formulations, adding value through ingredient sourcing and formulation expertise.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Multi-year contract | Development budget-driven engagement — early-stage consultation and formulation scoping |
| Unit Pricing | Annual | Regular batch manufacturing — ongoing production orders |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Lipa Pharmaceuticals Limited product offering
Product offeringCore offering
Lipa Pharmaceuticals is a B2B contract manufacturer of nutraceuticals and complementary medicines, producing finished supplements in multiple dosage formats under private label (fully customised) and white label (pre-formulated) arrangements. The company offers end-to-end capabilities spanning innovation discovery, formulation development, TGA/APVMA regulatory compliance, GMP-certified manufacturing, and packaging, with a specialist focus on probiotic manufacturing using qPCR strain-level validation and segregated HVAC environmental controls.
Product overview
Lipa Pharmaceuticals is an Australian contract manufacturer of nutraceuticals and complementary medicines offering both private label and white label solutions. The company operates a multi-format manufacturing capability producing supplements in Hard Shell Capsules, Soft Gel Capsules, Tablets, Powders, Liquids, and Serums/Gels/Creams. Lipa Advanced provides pre-formulated therapeutic white label products for faster market entry, while Private Label Innovation offers fully customized end-to-end solutions. The company specializes in probiotics, being Australia's first TGA-compliant probiotic contract manufacturer. Products are organized across innovation categories including Active Performance, Beauty & Skin Health, Cognitive Health, Collagen & Joint Health, Energy & Immunity Support, Healthy Ageing, Hydration Plus, Metabolic Health & Weight Management, Nutrients for Brain Health, Pet Supplements, and Probiotics & Gut Health.
Differentiator
Problem solved
Functional benefit
Brands
- Lipa Advanced: Advanced evidence-based therapeutic white label formulations using highest quality ingredients, fully compliant and ready for manufacture and launch.
- QualityShield+
Products and services
- Private Label Innovation End-to-end customised private label product innovation service for B2B clients, using Lipa's category knowledge and expertise to develop and manufacture fully customised high-quality nutraceutical and complementary medicine products aligned to the client's brand growth strategy, spanning categories such as active performance, beauty and skin health, cognitive health, collagen and joint health, energy and immunity, healthy ageing, metabolic health, and probiotics.
- Lipa Advanced White Label Formulations Pre-formulated, evidence-based therapeutic white label product range fully TGA-compliant and using high-quality ingredients, ready for client branding and manufacture. Categories include active performance, beauty and skin health, cognitive health, collagen and joint health, energy and immunity, healthy ageing, metabolic health, and probiotics. Designed for businesses seeking faster time-to-market with established science-based formulations.
- Probiotics Contract Manufacturing Specialist TGA-compliant probiotic contract manufacturing service featuring state-of-the-art in-house probiotic manufacturing with advanced post-biotics and spore-based products, fully segregated Probiotic HVAC air-quality and environmental controls, qPCR validation equipment for strain-level identification and enumeration, and world-class stability testing.
- Pet Supplements Manufacturing Contract manufacturing of APVMA-compliant pet supplements in multiple dosage formats for animal health brands, addressing species-specific bioavailability needs and Australian regulatory requirements for animal health products.
Quantifiable outcome
- Lipa has been awarded the CMA 'High-Quality Manufacturer of the Year Award' 8 times
- +3 more outcomes
Companies that use Lipa Pharmaceuticals Limited
Customer profileSegments3 records
Ideal customer profiles3 records
Lipa Pharmaceuticals Limited technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Lipa Pharmaceuticals Limited partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- BASFcoreBASF received TGA approval in March 2021 to supply Prebilac™ (2'-Fucosyllactose / 2'FL), the first-ever HMO probiotic approved for use as a prebiotic in dietary supplements in Australia. Under the arrangement, BASF is the only company allowed to supply Prebilac in Australia for two years. Lipa incorporates this ingredient into formulations for infant and adult health supplements.
- Pharmactive Biotech ProductscorePharmactive Biotech Products is a Spanish natural ingredient supplier and developer of affron® saffron extract and Olivactive® olive leaf extract. Lipa includes affron® as part of its key ingredient range and uses Pharmactive's ingredients in its formulations. affron® is a multi-award-winning ingredient recognised by Nutraingredients and Frost & Sullivan.
- Qualitas HealthcoreQualitas Health is the developer and supplier of Almega PL®, a plant-based omega-3 EPA ingredient derived from Nannochloropsis oculata microalgae. Almega PL® is included as a key ingredient in Lipa's product range and formulations, particularly for vegan and vegetarian supplement products.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Lipa Pharmaceuticals Limited competitors and assessment
Company assessmentOthers
- BGG (Beijing Gingko Group): Global ingredient supplier of botanical extracts, vitamins, and nutraceutical raw materials. Adjacent to Lipa's operations as a potential supplier or partner for ingredient sourcing, similar to Lipa's existing partnerships with Pharmactive, Qualitas Health, and BASF.
Broad incumbents
- Aenova Group: European pharmaceutical and nutraceutical contract manufacturer with multi-format capabilities (tablets, capsules, soft gels, liquids). Comparable to Lipa as a multi-format CMO but with substantially larger scale and broader geographic footprint.
- Catalent: Global CDMO with extensive pharmaceutical and consumer health manufacturing capabilities including softgel, tablet, and oral dose forms. Broader and larger than Lipa but operates in overlapping nutraceutical and OTC manufacturing services for brand owners.
Emerging players
- Bio-Botanica: US-based botanical extract manufacturer and custom formulation provider serving the supplement and personal care industries. Partial overlap with Lipa's ingredient sourcing and formulation expertise, particularly for botanical-based complementary medicine products.
Direct peers
- Makers Nutrition: US-based full-service supplement contract manufacturer offering private label and custom formulations in capsules, tablets, powders, and liquids. Comparable to Lipa as a B2B nutraceutical CMO targeting health and wellness brands with end-to-end services.
- Best Formulations: US-based contract manufacturer of vitamins, supplements, and nutraceuticals in multiple dosage formats. Closely comparable to Lipa in offering private label and custom formulation services to consumer health brands, with similar reliance on GMP-certified multi-format production.
- Nutrition Formulators: US contract manufacturer specialising in liquid, powder, capsule, and tablet dietary supplements for private label brands. Directly comparable to Lipa in offering multi-format B2B manufacturing services to supplement brand owners.
- Tishcon Corporation: US-based contract manufacturer of vitamins, supplements, and nutraceuticals in tablets, capsules, soft gels, and liquids. Directly comparable to Lipa's multi-format private label/contract manufacturing service offering for consumer health brands.
- Robinson Pharma: Large US contract manufacturer of dietary supplements in capsules, tablets, liquids, and powders. Comparable to Lipa as a B2B supplement CMO serving brand-owner customers with private label and custom manufacturing across multiple dosage forms.
Regional players
- Blackmores: Leading Australian branded complementary medicines and supplements company. While a brand owner (not a CMO), Blackmores is highly comparable to Lipa in product category, Australian market focus, and reliance on TGA-regulated complementary medicine frameworks, and represents both a competitor for Lipa's branded client base and a potential large-scale contract customer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Lipa Pharmaceuticals Limited social profiles
Digital presenceLipa Pharmaceuticals Limited compliance and trust
Trust signalCompliance6 records
Lipa Pharmaceuticals Limited financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lipa Pharmaceuticals Limited leadership team
Management profileNumber of profiles
Lipa Pharmaceuticals Limited funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lipa Pharmaceuticals Limited M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lipa Pharmaceuticals Limited
What does Lipa Pharmaceuticals Limited do?
Lipa Pharmaceuticals is a B2B contract manufacturer of nutraceuticals and complementary medicines, producing finished supplements in multiple dosage formats under private label (fully customised) and white label (pre-formulated) arrangements. The company offers end-to-end capabilities spanning innovation discovery, formulation development, TGA/APVMA regulatory compliance, GMP-certified manufacturing, and packaging, with a specialist focus on probiotic manufacturing using qPCR strain-level validation and segregated HVAC environmental controls.
Is Lipa Pharmaceuticals Limited a public or private company?
Lipa Pharmaceuticals Limited is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lipa Pharmaceuticals Limited founded?
Lipa Pharmaceuticals Limited was founded in 1995. It employs 101 to 250 people.
Where is Lipa Pharmaceuticals Limited based?
Lipa Pharmaceuticals Limited is headquartered in Minto, Australia, in the Oceania region.
How does Lipa Pharmaceuticals Limited make money?
Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are proprietary Ingredient Range.
Who are Lipa Pharmaceuticals Limited's main competitors?
BGG (Beijing Gingko Group) is listed as an others. Broad incumbents are Aenova Group and Catalent. Bio-Botanica is listed as an emerging player. Direct peers are Makers Nutrition, Best Formulations, Nutrition Formulators, Tishcon Corporation and Robinson Pharma. Blackmores is listed as a regional player.
Does Lipa Pharmaceuticals Limited have an API?
No public API is recorded for Lipa Pharmaceuticals Limited.
What industry is Lipa Pharmaceuticals Limited in?
Lipa Pharmaceuticals Limited's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of CRADAGAG, Weight Management & Metabolic Supplements. Its NAICS code is 325412 and its SIC code is 2000.